Zurich-based Rivia raises €3 million to address the critical inefficiencies in the current clinical trial process

Published on June 12, 2024

Rivia, a Swiss startup specializing in AI-driven analytics and clinical trial data infrastructure for Biotechs, has secured a €3 million seed funding round led by Speedinvest. The funds will be used to hire new teams across engineering and client services,  and will also advance product development to fully harness the potential of integrated trial data…

This content is for members only. Visit the site and log in/register to read.

The post Zurich-based Rivia raises €3 million to address the critical inefficiencies in the current clinical trial process appeared first on EU-Startups.